Individual provider · Type 1 NPI
Gabriela Anna Firak, DO
Endocrinology, Diabetes & Metabolism Physician · Lebanon, PA
Practice location
1700 S Lincoln Ave
Lebanon, PA 17042-7529
Other practice locations
- 420 South 5th Ave, West Reading, PA 19611-6202 · (484) 628-8000
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Endocrinology, Diabetes & Metabolism Physician Primary | 207RE0101X | OS019332 (PA) |
| Internal Medicine Physician | 207R00000X | OS019332 (PA) |
Endocrinology, Diabetes & Metabolism Physician: An internist who concentrates on disorders of the internal (endocrine) glands such as the thyroid and adrenal glands. This specialist also deals with disorders such as diabetes, metabolic and nutritional disorders, obesity, pituitary diseases and menstrual and sexual problems.
437 other providers at this address
- Department of Veterans Affairs, Va Medical Center, Lebanon Pa.VA Clinic/Center Lebanon, PA NPI 1104250927
- Lebanon Va Medical CenterVA Clinic/Center Lebanon, PA NPI 1558445130
- Lebanon VamcGeneral Acute Care Hospital Lebanon, PA NPI 1124077672
- Abby Marie Skripko, PA-CMedical Physician Assistant Lebanon, PA NPI 1164836144
- Abigail L. Noll, MSWSocial Worker Lebanon, PA NPI 1730065756
- Adam Eric PennPharmacist Lebanon, PA NPI 1306512876
- Adrienne EllingerPharmacist Lebanon, PA NPI 1124869839
- Aimee A. Arnold, R.D.H.Dental Hygienist Lebanon, PA NPI 1649368390
- Airika Pollard, LSWSocial Worker Lebanon, PA NPI 1013491471
- Alex SilvestriSocial Worker Lebanon, PA NPI 1639069602
- Alexandra Elizabeth Cerino, PharmDPharmacist Lebanon, PA NPI 1962096776
- Alexi Achenbach, MDGynecology Physician Lebanon, PA NPI 1932397452
Other endocrinology, diabetes & metabolism physician providers in Lebanon
About NPI 1689052334
Gabriela Anna Firak, DO's National Provider Identifier is 1689052334, issued on May 14, 2015. The primary taxonomy on file is Endocrinology, Diabetes & Metabolism Physician (207RE0101X), and the practice location is in Lebanon, PA. The record was last updated on Dec 17, 2025.